The landmark text in medical pharmacology is now in full colorIncludes DVD with image bankA Doody's Core Title for 2017!4 STAR DOODY'S REVIEW!"This 12th edition of the most authoritative book in pharmacology is the best both in content and physical appearance....This edition of Goodman & Gilman's continues to be the most authoritative and widely used resource bridging the discipline of pharmacology with therapeutics. Moreover, readers will find this edition to be substantially improved from past editions in both content and physical appearance."--Doody's Review ServiceThe most universally respected and read medical text in all of pharmacology, Goodman & Gilman's The Pharmacological Basis of Therapeutics represents the pinnacle of authority and accuracy in describing the actions and uses of therapeutic agents in relation to physiology and pathophysiology. Goodman & Gilman's careful balance of basic science and clinical application has guided thousands of practitioners and students to a clear understanding of the drugs essential to preventing, diagnosing, and treating disease.Enriched by a new full-color presentation and updated to reflect all critical new developments in drug action and drug-disease interaction, the twelfth edition includes more than 440 color illustrations depicting key principles and actions of specific pathways and therapeutic agents. The companion DVD includes all the images and tables in the text along with narrated animations.Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e is divided into nine sections, covering:General PrinciplesNeuropharmacologyModulation of Cardiovascular FunctionInflammation, Immunomodulation, and HematopoiesisEndocrine PharmacologyGastrointestinal PharmacologyChemotherapy of Infectious DiseaseChemotherapy of Neoplastic DiseasesSpecial Systems PharmacologyMore than a textbook, Goodman & Gilman's is a working template for the effective and rational prescribing of drugs in daily practice.
Les mer
The "Harrison's of Pharmacology" -- now in full color
Contributors Consultants to the Editors Preface Preface to the First Edition SECTION I: GENERAL PRINCIPLES 1. Drug Invention and the Pharmaceutical Industry, Suzanne M. Rivera and Alfred Goodman Gilman 2. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination, Iain L. O. Buxton and Leslie Z. Benet 3. Pharmacodynamics: Molecular Mechanisms of Drug Action, Donald K. Blumenthal and James C. Garrison 4. Drug Toxicity and Poisoning, Kevin C. Osterhoudt and Trevor M. Penning 5. Membrane Transporters and Drug Response, Kathleen M. Giacomini and Yuichi Sugiyama 6. Drug Metabolism, Frank J. Gonzalez, Michael Coughtrie, and Robert H. Tukey 7. Pharmacogenetics, Mary V. Relling and Kathleen M. Giacomini SECTION II: NEUROPHARMACOLOGY 8. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems, Thomas C. Westfall and David P. Westfall 9. Muscarinic Receptor Agonists, Joan Heller Brown and Nora Laiken 10. Anticholinesterase Agents, Palmer Taylor 11. Agents Acting at the Neuromuscular Junction and Autonomic Ganglia, Ryan E. Hibbs and Alexander C. Zambon 12. Adrenergic Agonists and Antagonists, Thomas C. Westfall and David P. Westfall 13. 5-Hydroxytryptamine (Serotonin) and Dopamine, Elaine Sanders-Bush and Lisa Hazelwood 14. Neurotransmission and the Central Nervous System, Perry B. Molinoff 15. Drug Therapy of Depression and Anxiety Disorders, James M. O'Donnell and Richard C. Shelton 16. Pharmacotherapy of Psychosis and Mania, Jonathan M. Meyer 17. Hypnotics and Sedatives, S. John Mihic and r. Adron Harris 18. Opioids, Analgesia, and Pain Management, Tony L. Yaksh and Mark S. Wallace 19. General Anesthetics and Therapeutic Gases, Piyush M. Patel, Hemal H. Patel, and David M. Roth 20. Local Anesthetics, William A. Catteral nad Kenneteh Mackie 21. Pharmacotherapy of the Epilepsies, James O. McNamara 22. Treatment of Central Nervous System Degenerative Disorders, David G. Standaert and Erik D. Roberson 23. Ethanol and Methanol, Marc A. Schuckit 24. Drug Addition, Charles P. O'Brien SECTION III: MODULATION OF CARDIOVASCULAR FUNCTION 25. Regulation of Renal Function and Vascular Volume, Robert F. Reilly and Edwin K. Jackson 26. Renin and Angiotensin, Randa Hilal-Dandan 27. Treatment of Myocardial Ischemia and Hypertension, Thomas Michel and Brian B. Hoffman 28. Pharmacotherapy of Congestive Heart Failure, Bradley A. Maron and Thomas P. Rocco 29. Anti-Arrhythmic Drugs, Kevin J. Sampson and Robert S. Kass 30. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs, Jeffrey I. Weitz 31. Drug Therapy for Hypercholesterolemia and Dyslipiedmia, Thomas P. Bersot SECTION IV: INFLAMMATION, IMMUNOMODULATION, AND HEMATOPOIESIS 32. Histamine, Bradykinin, and Their Antagonists, Randal A. Skidgel, Allen P. Kaplan, and Ervin G. Erdoes 33. Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor, Emer M. Smyth, Tilo Grosser, and Garret A. Fitzgerald 34. Anti-inflammatory, Antipyretic, and Analgesic Agents; Pharmacology of Gout, Tilo Grosser, Emer Smyth, and Garret A. FitzGerald 35. Immunosupressants, Tolerogens, and Immunostimulants, Alan M. Krensky, William M. Bennett, and Flavio Vincenti 36. Pulmonary Pharmacology, Peter J. Barnes 37. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins, Kenneth Kaushansky and Thomas J. Kipps SECTION V: HORMONES AND HORMONE ANTAGONISTS 38. Introduction to Endocrinology: The Hypothalamic-Pituitary Axis, Keith L. Parker and Bernard P. Schimmer 39. Thyroid and Anti-Thyroid Drugs, Gregory A. Brent and Ronald J. Koenig 40. Estrogens and Progestins, Ellis R. Levin and Stephen R. Hammes 41. Androgens, Peter J. Snyder 42. ACTH, Adrenal Steroids, and Pharmacology of the Adrenal Cortex, Bernard P. Schimmer and John W. Funder 43. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia, Alvin C. Powers and David D'Alessio 44. Agents Affecting Mineral Ion Homeostatis and Bone Turnover, Peter A. Friedman SECTION VI: DRUGS AFFECTING GASTROINTESTINAL FUNCTION 45. Pharmacotherapy of Gastric Acidity, Peptic Ulcers, and Gastroesophageal Reflux Disease, John L. Wallace and Keith A. Sharkey 46. Treatment of Disorders of Bowel Motility and Water Flux: Anti-Emetics; Agents Used in Biliary and Pancreative Disease, Keith A. Sharkey and John L. Wallace 47. Pharmacotherapy of Inflammatory Bowel Disease, John L. Wallace and Keith A. Sharkey SECTION VII: CHEMOTHERAPY OF MICROBIAL DISEASES 48. General Principles of Antimicrobial Therapy, Tawanda Gumbo 49. Chemotherapy of Malaria, Joseph M. Vinetz, Jerome Clain, Viengngeun Bounkeua, Richard T. Eastman, and David Fidock 50. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections, Margaret A. Phillips, Samuel L. Stanley, Jr. 51. Chemotherapy of Helminth Infections, James McCarthy, Alex Loukas, and Peter J. Hotez 52. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections, William A. Petri, Jr. 53. Penicillins, Cephalosporins, and Other ss-Lactam Antibiotics, William A. Petri, Jr. 54. Aminoglycosides, Conan MacDougall and Henry F. Chambers 55. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents, Conan MacDougall and Henry F. Chambers 56. Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease, and Leprosy, Tawanda Gumbo 57. Antifungal Agents, John E. Bennett 58. Antiviral Agents (Nonretroviral), Edward P. Acosta and Charles Flexner 59. Antiretroviral Agents and Treatment of HIV Infection, Charles Flexner SECTION VIII: CHEMOTHERAPY OF NEOPLASTIC DISEASES 60. General Principles of Cancer Chemotherapy, Bruce A. Chabner 61. Cytotoxic Agents, Bruce A. Chabner, Joseph Bertino, James Cleary, Taylor Ortiz, Andrew Lane, Jeffrey G. Supko, and David Ryan 62. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, Bruce A. Chabner, Jeffrey Barnes, Joel Neal, Erin Olson, Hamza Mujagic, Lecia Sequist, Wynham Wilson, Dan L. Longo, Constantine Mitsiades, and Paul Richardson 63. Natural Products in Cancer Chemotherapy: Hormones and Related Agents, Beverly Moy, Paul Goss, Richard J. Lee, and Matthew Smith SECTION IX: OPHTHALMOLOGY 64. Ocular Pharmacology, Jeffrey D. Henderer and Christopher J. Rapuano 65. Dermatological Pharmacology, Craig Burkhart, Dean Morrell, and Lowell Goldsmith 66. Contraception and Pharmacotherapy of Obstetrical and Gynecological Disorders, Bernard P. Schimmer and Keith L. Parker 67. Environmental Toxicology: Carcinogens and Heavy Metals, Michael C. Byrns and Trevor M. Penning APPENDICES I. Principles of Prescription Order Writing and Patient Compliance, Iain L.O. Buxton II. Design and Optimization of Dosage Regimens: Pharmacokinetic Data, Kenneth E. Thummel, Danny D. Shen, and Nina Isoherranen Index
Les mer

Produktdetaljer

ISBN
9780071624428
Publisert
2011-02-16
Utgave
12. utgave
Utgiver
Vendor
McGraw-Hill Medical
Vekt
3789 gr
Høyde
262 mm
Bredde
211 mm
Dybde
70 mm
Aldersnivå
06, P
Språk
Product language
Engelsk
Format
Product format
Annet
Antall sider
1808

Biographical note

Editor:
Laurence L. Brunton, PhD
Professor of Pharmacology and Medicine
University of California San Diego
School of Medicine
La Jolla, CA

Associate Editors:
Bruce A. Chabner, MD
Clinical Director
MDF Cancer Center
Professor of Medicine
Harvard Medical School
Boston, MA
Bjorn Christian Knollmann, MD, PhD
Associate Professor of Medicine and Pharmacology
Oates Institute for Experimental Therapeutics
Vanderbilt University School of Medicine
Division of Clinical Pharmacology
Nashville, TN